Your browser doesn't support javascript.
loading
Successful Renal Transplant in End-Stage Renal Disease with Chronic Immune Thrombocytopenia using Thrombopoietin Receptor Agonists and Intravenous Immunoglobulin.
Behera, Vineet; K P, Rohith; Chauhan, Prabhat; Meshram, Ashok; Dhawan, Vikas; Ananthakrishnan, Ramamoorthy; Hande, Vivek.
Afiliação
  • Behera V; Nephrologist and Associate Professor Medicine, INHS Asvini, Mumbai, Maharashtra, India.
  • K P R; Senior Resident Medicine, INHS Asvini, Mumbai, Maharashtra, India.
  • Chauhan P; Nephrologist, INHS Asvini, Mumbai, Maharashtra, India.
  • Meshram A; Hematologist, INHS Asvini, Mumbai, Maharashtra, India.
  • Dhawan V; Urologist, INHS Asvini, Mumbai, Maharashtra, India.
  • Ananthakrishnan R; Professor Medicine and Cardiology, INHS Asvini, Mumbai, Maharashtra, India.
  • Hande V; Professor Medicine and Gastroenterology, INHS Asvini, Mumbai, Maharashtra, India.
Indian J Nephrol ; 34(2): 185-188, 2024.
Article em En | MEDLINE | ID: mdl-38681008
ABSTRACT
Chronic kidney disease in immune thrombocytopenia (ITP) is uncommon, and renal transplant in this setting is rare. We discuss the successful renal transplant of a 29-year-old male with chronic ITP. During transplant, he was managed with thrombopoietin receptor agonist eltrombopag, intravenous methylprednisone, and intravenous immunoglobulin to maintain adequate platelet level. He recovered well with no major complications and good graft function and has been stable during the follow-up period. The case report highlights that renal transplantation is a feasible option in patients with ITP, even in the presence of low platelet counts.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article